BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8785951)

  • 1. Alternatives to animal testing: achievements and recent developments in the European Pharmacopoeia.
    Castle P
    Dev Biol Stand; 1996; 86():21-9. PubMed ID: 8785951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternatives to animals in the development and control of biological products for human and veterinary use. The role of the European Pharmacopoeia.
    Artiges A
    Dev Biol Stand; 1999; 101():29-35. PubMed ID: 10566772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormones: the role of the European Pharmacopoeia.
    Charton E
    Dev Biol Stand; 1999; 101():159-67. PubMed ID: 10566789
    [No Abstract]   [Full Text] [Related]  

  • 4. [Development of alternative methods by the EDQM and the Biological Standardization Program].
    Buchheit KH
    ALTEX; 2001; 18(1):19-22. PubMed ID: 11248845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrogen testing of lipidic parenterals with a novel in vitro test--application of the IPT based on cryopreserved human whole blood.
    Schindler S; Rosenberg U; Schlote D; Panse K; Kempe A; Fennrich S; Hartung T
    Pharmeur Sci Notes; 2006 Aug; 2006(1):1-7. PubMed ID: 17694639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The three Rs of Russell & Burch and the testing of biological products.
    Balls M; Straughan DW
    Dev Biol Stand; 1996; 86():11-8. PubMed ID: 8785939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in the replacement of animal experiments in the quality control of clostridial vaccines].
    Cussler K; Borrmann E; Werner E
    Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):172-7. PubMed ID: 11998369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement, Reduction, Refinement - Animal welfare progress in European Pharmacopoeia monographs: activities of the European Pharmacopoeia Commission from 2007 to 2017.
    Lang C; Kolaj-Robin O; Cirefice G; Taconet L; Pel E; Jouette S; Buda M; Milne C; Charton E
    Pharmeur Bio Sci Notes; 2018; 2018():12-36. PubMed ID: 29845933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["Replacement Methods to Animal Testing" as the incentive topic of the German Ministry of Education and Research. Selected results on biological drugs].
    Diekmann W; Hansper M
    ALTEX; 2001; 18(1):23-8. PubMed ID: 11248846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possibilities of replacing and reducing animal tests in the pharmacopoeias: an evaluation of unused methods and proposals for change.
    Miethe G
    Altern Lab Anim; 2002; 30(2):229-40. PubMed ID: 11971758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacopoeia as quality codex for the manufacturers.
    Soldi A
    Ann Ist Super Sanita; 1975; 11(3-4):269-80. PubMed ID: 1234728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three Rs potential in the development and quality control of pharmaceuticals.
    Hartung T
    ALTEX; 2001; 18 Suppl 1():3-13. PubMed ID: 11854852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacement, reduction or refinement of animal use in the quality control of veterinary vaccines: development, validation and implementation.
    van der Kamp MD
    Dev Biol Stand; 1996; 86():73-6. PubMed ID: 8785994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraneous agents testing for substrates of avian origin and viral vaccines for poultry: current provisions and proposals for future approaches.
    Jungbäck C; Motitschke A
    Biologicals; 2010 May; 38(3):362-5. PubMed ID: 20335053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The target animal safety test--is it still relevant?
    Advisory Group on Alternatives to Animal Testing in Immunobiologicals
    Biologicals; 2002 Dec; 30(4):277-87. PubMed ID: 12474863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Animal experiments in the context of quality control of pharmaceuticals. Review of the European Pharmacopoeia, 4th edition, 2002].
    Sponer G
    ALTEX; 2004; 21(2):73-80. PubMed ID: 15195228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of animal usage: British Pharmacopoeia Commission policy.
    Rabouhans ML
    Dev Biol Stand; 1986; 64():11-6. PubMed ID: 3792640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developments in pertussis vaccines leading to reduction and replacement of in vivo testing.
    Redhead K
    Dev Biol Stand; 1996; 86():263-70. PubMed ID: 8785955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative study for the establishment of two European Pharmacopoeia Biological Reference Preparations for serological potency testing of tetanus vaccines for veterinary use.
    Lensing HH; Behr-Gross ME; Daas A; Spieser JM
    Dev Biol (Basel); 2002; 111():69-76. PubMed ID: 12678226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.